Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer

Cancer

Volumn 119, Issue 21, 2013, Pages 3753-3760

  Eaton, Bree R ^a   Kim, Sungjin ^b   Marcus, David M ^a   Prabhu, Roshan ^a   Chen, Zhengjia ^b   Ramalingam, Suresh S ^a   Curran, Walter J ^a   Higgins, Kristin A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

age; elderly; lung cancer; prophylactic cranial irradiation; small cell

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ELDERLY CARE; EXPLORATORY RESEARCH; FEMALE; GERIATRIC PATIENT; HUMAN; LUNG SMALL CELL CANCER; LUNG SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SKULL IRRADIATION;

EID: 84886098918     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28267     Document Type: Article

References (25)

1. Gaspar LE, Gay EG, Crawford J, Putnam JB, Herbst RS, Bonner JA,. Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base. Clin Lung Cancer. 2005; 6: 355-360.
2. Lally BE, Geiger AM, Urbanic JJ, et al. Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer. 2009; 64: 226-231.
3. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999; 341: 476-484.
4. Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol. 2009; 10: 467-474.
5. Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011; 81: 77-84.
6. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007; 357: 664-672.
7. Socha J, Kepka L,. Prophylactic cranial irradiation for small-cell lung cancer: how, when and for whom? Expert Rev Anticancer Ther. 2012; 12: 505-517.
8. Bremnes RM, Sundstrom S, Aasebo U, Kaasa S, Hatlevoll R, Aamdal S,. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer. 2003; 39: 303-313.
9. Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N,. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer. 1987; 39: 146-149.
10. Maestu I, Pastor M, Gomez-Codina J, et al. Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of 3 known prognostic indices on 341 patients. Ann Oncol. 1997; 8: 547-553.
11. Pal SK, Hurria A,. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol. 2010; 28: 4086-4093.
12. Extermann M,. Interaction between comorbidity and cancer. Cancer Control. 2007; 14: 13-22.
13. Gondi V, Paulus R, Bruner DW, et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of radiation therapy oncology group randomized trials 0212 and 0214. Int J Radiat Oncol Biol Phys. 2013; 86: 656-664.
14. Flood KL, Carroll MB, Le CV, Ball L, Esker DA, Carr DB,. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol. 2006; 24: 2298-2303.
15. Hurria A, Kris MG,. Management of lung cancer in older adults. CA Cancer J Clin. 2003; 53: 325-341.
16. National Cancer Institute: Surveillance, Epidemiology, and End Results. Overview of the SEER Program. seer.cancer.gov/about/overview.html. Access date April 29th 2013.
17. Park HS, Gross CP, Makarov DV, Yu JB,. Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2012; 83: 1365-1373.
18. Kalbfleisch JD, Prentice RL,. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons; 1980.
19. Cox D,. Regression models and life tables. J R Stat Soc B. 1972; 34: 187-220.
20. Patel S, Macdonald OK, Suntharalingam M,. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Cancer. 2009; 115: 842-850.
21. Schild SE, Foster NR, Meyers JP, et al. North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012; 23: 2919-2924.
22. Ludbrook JJ, Truong PT, MacNeil MV, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys. 2003; 55: 1321-1330.
23. Le Pechoux C, Laplanche A, Faivre-Finn C, et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol. 2011; 22: 1154-1163.
24. Crossen JR, Garwood D, Glatstein E, Neuwelt EA,. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 1994; 12: 627-642.
25. National Comprehensive Cancer Network. NCCN Guidelines. Small Cell Lung Cancer. wwww.nccn.org. Accessed April 29th 2013.